Chief medical adviser at Health Canada says evidence is that the vaccine is safe and effective in the younger age group
WEDNESDAY, May 5, 2021 (HealthDay News) — The Pfizer COVID-19 vaccine has been approved by Canadian health officials for use in children ages 12 to 15 years. It was already authorized for anyone 16 years and older.
The evidence is that the vaccine is safe and effective in the younger age group, Supriya Sharma, M.D., chief medical adviser at Health Canada, said Wednesday, the Associated Press reported. The Pfizer COVID-19 vaccine is the first approved for children in Canada.
In the United States, the Food and Drug Administration is expected to authorize the Pfizer vaccine for youngsters by next week, meaning that many may be able to get shots before the start of the next school year, the AP reported.
About a month ago, Pfizer announced that its vaccine also provides protection for children ages 12 to 15 years.
Nutritional Deficiencies Seen in Youth Taking GLP-1 Receptor Agonists 
Nearly 3 in 4 Older Adults Express Interest in Vaccine to Prevent Dementia 
Youth Suicide Risk Linked to Community Firearm Violence 
Updated COVID-19 Shot Beneficial for Those With Autoimmune Rheumatic Disease 
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported 
Trends Reported in Vaccination Coverage for Adolescents for 2025 
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season 
Distinct Characteristics ID"d for Patients With Rheumatoid Conditions, Opioid Use Disorder 
